Varex Imaging (VREX) Receiving Somewhat Positive Press Coverage, Report Shows

News headlines about Varex Imaging (NASDAQ:VREX) have trended somewhat positive on Sunday, according to Accern. The research firm identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Varex Imaging earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.5493967446864 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

These are some of the news articles that may have impacted Accern’s scoring:

Shares of Varex Imaging stock opened at $37.50 on Friday. The firm has a market capitalization of $1.42 billion, a price-to-earnings ratio of 20.83, a price-to-earnings-growth ratio of 2.03 and a beta of 2.46. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.46 and a current ratio of 3.25. Varex Imaging has a 52 week low of $27.80 and a 52 week high of $43.76.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings data on Thursday, May 3rd. The company reported $0.45 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.45. The company had revenue of $201.20 million for the quarter, compared to the consensus estimate of $187.33 million. Varex Imaging had a return on equity of 16.74% and a net margin of 6.43%. Varex Imaging’s quarterly revenue was up 30.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.43 EPS. equities analysts expect that Varex Imaging will post 1.85 EPS for the current fiscal year.

VREX has been the topic of several research analyst reports. Zacks Investment Research downgraded Varex Imaging from a “buy” rating to a “hold” rating in a research report on Thursday, May 10th. Sidoti initiated coverage on Varex Imaging in a research report on Thursday, April 19th. They issued a “neutral” rating on the stock.

In other Varex Imaging news, insider Kevin Bruce Yankton sold 862 shares of the company’s stock in a transaction on Monday, May 14th. The stock was sold at an average price of $37.00, for a total value of $31,894.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Kimberley E. Honeysett sold 2,000 shares of the company’s stock in a transaction on Monday, April 16th. The shares were sold at an average price of $37.68, for a total value of $75,360.00. Following the completion of the transaction, the senior vice president now directly owns 916 shares in the company, valued at approximately $34,514.88. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

About Varex Imaging

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers, and buckys.

Insider Buying and Selling by Quarter for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply